Advertisement
Screener

OPKO Health, Inc. (OPK) Repayments of Senior Debt

1.5 / 5 stars · 26/87 Roast Me

OPKO Health, Inc. Repayments of Senior Debt

OPKO Health, Inc. (OPK) reported Repayments of Senior Debt of $174.00 thousand for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-01.

Financial Statements › Cash Flow › Financing Activities

us-gaap:RepaymentsOfSeniorDebt · last filed 2025-05-01

  • OPKO Health, Inc. repayments of senior debt for the quarter ending 2025-03-31 was $174.00K, a 99.88% decline year-over-year.
  • OPKO Health, Inc. repayments of senior debt for the quarter ending 2024-12-31 was $0.00.
  • OPKO Health, Inc. repayments of senior debt for the quarter ending 2024-09-30 was $0.00.
  • OPKO Health, Inc. repayments of senior debt for the quarter ending 2024-06-30 was $0.00.
  • OPKO Health, Inc. repayments of senior debt for fiscal 2024 was $146.29M, a 4776.23% increase from fiscal 2023.
  • OPKO Health, Inc. repayments of senior debt for fiscal 2023 was $3.00M.
  • OPKO Health, Inc. repayments of senior debt for fiscal 2022 was $0.00.
  • OPKO Health, Inc. repayments of senior debt for fiscal 2021 was $0.00.
Period endRepayments of Senior Debt 3 monthRepayments of Senior Debt 6 monthRepayments of Senior Debt 9 monthRepayments of Senior Debt 12 month
2025-03-31$174.00K
10-Q · filed 2025-05-01
$174.00K
derived: sum of 2 quarters · filed 2025-05-01
$174.00K
derived: sum of 3 quarters · filed 2025-05-01
$174.00K
derived: sum of 4 quarters · filed 2025-05-01
2024-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03
$0.00
derived: sum of 2 quarters · filed 2025-03-03
$0.00
derived: sum of 3 quarters · filed 2025-03-03
$146.29M
10-K · filed 2025-03-03
2024-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07
$0.00
derived: sum of 2 quarters · filed 2024-11-07
$146.29M
10-Q · filed 2024-11-07
$146.29M
derived: sum of 4 quarters · filed 2025-05-01
2024-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07
$146.29M
10-Q · filed 2024-08-07
$146.29M
derived: sum of 3 quarters · filed 2025-05-01
$146.29M
derived: sum of 4 quarters · filed 2025-05-01
2024-03-31$146.29M
10-Q · filed 2025-05-01
$146.29M
derived: sum of 2 quarters · filed 2025-05-01
$146.29M
derived: sum of 3 quarters · filed 2025-05-01
$146.29M
derived: sum of 4 quarters · filed 2025-05-01
2023-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03
$0.00
derived: sum of 2 quarters · filed 2025-03-03
$0.00
derived: sum of 3 quarters · filed 2025-03-03
$3.00M
10-K · filed 2025-03-03
2023-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07
$0.00
derived: sum of 2 quarters · filed 2024-11-07
$3.00M
10-Q · filed 2024-11-07
$3.00M
derived: sum of 4 quarters · filed 2025-03-03
2023-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07
$3.00M
10-Q · filed 2024-08-07
$3.00M
derived: sum of 3 quarters · filed 2025-03-03
$3.00M
derived: sum of 4 quarters · filed 2025-03-03
2023-03-31$3.00M
10-Q · filed 2024-05-07
$3.00M
derived: sum of 2 quarters · filed 2025-03-03
$3.00M
derived: sum of 3 quarters · filed 2025-03-03
$3.00M
derived: sum of 4 quarters · filed 2025-03-03
2022-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03
$0.00
derived: sum of 2 quarters · filed 2025-03-03
$0.00
derived: sum of 3 quarters · filed 2025-03-03
$0.00
10-K · filed 2025-03-03
2022-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06
$0.00
derived: sum of 2 quarters · filed 2023-11-06
$0.00
10-Q · filed 2023-11-06
2022-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03
$0.00
10-Q · filed 2023-08-03
2022-03-31$0.00
10-Q · filed 2023-05-03
2021-12-31$0.00
10-K · filed 2024-03-01
2020-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01
$0.00
derived: sum of 2 quarters · filed 2022-03-01
$0.00
derived: sum of 3 quarters · filed 2022-03-01
$0.00
10-K · filed 2022-03-01
2020-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29
$0.00
derived: sum of 2 quarters · filed 2020-10-29
$0.00
10-Q · filed 2020-10-29
$0.00
derived: sum of 4 quarters · filed 2022-03-01
2020-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31
$0.00
10-Q · filed 2020-07-31
$0.00
derived: sum of 3 quarters · filed 2022-03-01
$0.00
derived: sum of 4 quarters · filed 2022-03-01
2020-03-31$0.00
10-Q · filed 2020-05-06
$0.00
derived: sum of 2 quarters · filed 2022-03-01
$0.00
derived: sum of 3 quarters · filed 2022-03-01
$0.00
derived: sum of 4 quarters · filed 2022-03-01
2019-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01
$0.00
derived: sum of 2 quarters · filed 2022-03-01
$0.00
derived: sum of 3 quarters · filed 2022-03-01
$28.80M
10-K · filed 2022-03-01
2019-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29
$0.00
derived: sum of 2 quarters · filed 2020-10-29
$28.80M
10-Q · filed 2020-10-29
$28.80M
derived: sum of 4 quarters · filed 2021-02-18
2019-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31
$28.80M
10-Q · filed 2020-07-31
$28.80M
derived: sum of 3 quarters · filed 2021-02-18
$28.80M
derived: sum of 4 quarters · filed 2021-02-18
2019-03-31$28.80M
10-Q · filed 2020-05-06
$28.80M
derived: sum of 2 quarters · filed 2021-02-18
$28.80M
derived: sum of 3 quarters · filed 2021-02-18
$28.80M
derived: sum of 4 quarters · filed 2021-02-18
2018-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-18
$0.00
derived: sum of 2 quarters · filed 2021-02-18
$0.00
derived: sum of 3 quarters · filed 2021-02-18
$0.00
10-K · filed 2021-02-18
2018-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05
$0.00
derived: sum of 2 quarters · filed 2019-11-05
$0.00
10-Q · filed 2019-11-05
2018-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07
$0.00
10-Q · filed 2019-08-07
2018-03-31$0.00
10-Q · filed 2019-05-08
2017-12-31$0.00
10-K · filed 2020-03-02

Similar stocks

Stock NameCountryMarket CapPE Ratio
LB PHARMACEUTICALS INC (LBRX)United States$1.220B-10.87
HARROW, INC. (HROW)United States$1.240B-42.77
Damora Therapeutics, Inc. (DMRA)$1.250B-6.10
Jaguar Health, Inc. (JAGX)United States$1.184B
Latigo Biotherapeutics, Inc. (LTGO)United States$1.176B
Avalyn Pharma Inc. (AVLN)United States$1.267B
First Tracks Biotherapeutics, Inc. (TRAX)United States$1.280B
Bicara Therapeutics Inc. (BCAX)United States$1.309B-10.55
Seaport Therapeutics, Inc. (SPTX)United States$1.131B
Amphastar Pharmaceuticals, Inc. (AMPH)United States$1.116B10.93